RecruitingPHASE1, PHASE2NCT05230680
Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype (ACANTUS)
Studying Nodal T-follicular helper cell lymphoma, follicular type
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Won Seog Kim
- Intervention
- ACHOP(drug)
- Enrollment
- 41 target
- Eligibility
- 20-85 years · All sexes
- Timeline
- 2022 – 2026
Study locations (1)
- 81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea, Seoul, South Korea
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05230680 on ClinicalTrials.govOther trials for Nodal T-follicular helper cell lymphoma, follicular type
Additional recruiting or active studies for the same condition.
See all trials for Nodal T-follicular helper cell lymphoma, follicular type →